Copper IUD: Benefits, Risks, and Alternatives

Contraceptive Efficacy and Benefits

The copper IUD is a highly effective, hormone-free contraceptive option with a failure rate of less than 1%, effective for at least 10 years, and provides immediate return to fertility upon removal 1, 2
Highly effective contraception with typical failure rates of less than 1% per year, comparable to sterilization 1, 2
Effective for at least 10 years, with data supporting use up to 12 years 3, 2
Does not require daily adherence or user action after insertion, making it more effective than methods requiring consistent user compliance 1
No hormonal side effects, completely hormone-free option 1, 2
No increased risk of venous thromboembolism (VTE), making it ideal for patients with thrombotic risk factors 4, 5, 6
Can be used as emergency contraception with the highest efficacy (<1% failure rate) when inserted within 5 days of unprotected intercourse 1, 2
Immediate return to fertility upon removal with no waiting period required 7

Safe for immunocompromised patients, including those with HIV, on immunosuppressive therapy, or solid organ transplant recipients 4, 1, 3, 5
Appropriate for nulliparous adolescents, does not cause tubal infertility 3, 8

Increased menstrual bleeding and cramping, particularly during the first several months after insertion 4, 1, 5, 6, 2
Small increased risk of pelvic infection during the first 20 days after insertion, but not beyond this period 8
No increased infection risk in immunocompromised patients, including those with HIV or on immunosuppressive therapy 4, 1, 3, 5
Contraindicated in current or recent pelvic inflammatory disease, current gonorrhea, chlamydia, or purulent cervicitis, pregnancy, and uterine anomalies that distort the cavity incompatible with insertion 8

Hormonal IUD (Levonorgestrel-Releasing) has similar contraceptive efficacy, reduces menstrual bleeding, and has no increased VTE risk 1, 3, 2
Progestin-Only Pills are less effective, require strict daily adherence, and have no increased VTE risk 1, 2
Progestin Implant (Etonogestrel) has the highest contraceptive efficacy, is effective for 3 years, and has minimal to no bone loss 1, 2
Depot Medroxyprogesterone Acetate (DMPA) has a typical failure rate of ~6%, administered every 12 weeks, and has a black box warning for decreased bone density 1, 3, 2
Combined Hormonal Contraceptives are contraindicated in multiple conditions, have a high VTE risk, and are acceptable in compensated cirrhosis and most other chronic liver diseases 4, 1, 5, 6, 2

The Centers for Disease Control and Prevention recommends that copper IUDs are effective for at least 10-12 years, and levonorgestrel IUDs, such as Kyleena, are approved for 5 years 9, 10

The American College of Obstetricians and Gynecologists notes that copper IUDs increase menstrual bleeding and cramping, particularly during the first several months after insertion, and may require NSAIDs for 5-7 days during bleeding episodes 9
The Arthritis and Rheumatology journal recommends that levonorgestrel IUDs, such as Kyleena, decrease menstrual bleeding significantly and may lead to amenorrhea in some women, making them particularly beneficial for patients on anticoagulation therapy 10

The American College of Rheumatology states that copper IUDs are a completely hormone-free option with no systemic hormonal effects, and no increased risk of venous thromboembolism, making them ideal for patients with contraindications to hormones 10
The Centers for Disease Control and Prevention recommends that levonorgestrel IUDs contain progestin only, with no increased risk of venous thromboembolism, and are strongly recommended over combined estrogen-progestin contraceptives in patients with certain medical conditions 10, 11, 12

The Centers for Disease Control and Prevention advises that no routine follow-up visit is required after IUD insertion, and that IUDs are safe for immunocompromised patients, including those with HIV or on immunosuppressive therapy 9, 11, 13
The American College of Obstetricians and Gynecologists recommends that bleeding pattern changes do not correlate with contraceptive failure, and reassurance is key for patients experiencing bleeding irregularities 9, 13